Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

Although neurotrophic keratitis (NK) is considered a rare eye disease, it is a degenerative corneal disease that can profoundly affect patients' lives. Left untreated, NK can lead to corneal ulceration, melting, and perforation, which can ultimately lead to vision loss. In this podcast, experts Quan Dong Nguyen, MD, MSc; and Cecelia Koetting, OD, FAAO, DipABO; discuss the diagnosis, staging, and treatment of NK, focusing on early-stage disease.

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from Dompé US, Inc.

Quan Dong Nguyen, MD, MSc

Professor of Ophthalmology
Byers Eye Institute, Stanford University School of Medicine
Stanford, CA

Disclosure: Research Support: Active Biotech, Genentech, Oculis, Priovant, Regeneron; Advisory Boards: Kriya, Oculis, Priovant, Regeneron.

Cecelia Koetting, OD, FAAO, DipABO

Clinical Instructor
Department of Ophthalmology
University of Colorado School of Medicine
Denver, CO

Disclosure: Grant Support: KALA BIO, Ocular Therapeutix, Tarsus Pharmaceuticals, Viatris; Consultant: AbbVie, Alcon, Aldeyra Therapeutics, Azura Ophthalmics, Bausch + Lomb, Blinkjoy, Bruder Healthcare, Dompé US, Glaukos, Myze, Orasis Pharmaceuticals, Sight Sciences, Tarsus Pharmaceuticals, Théa Pharma, Topcon Healthcare, Twenty/Twenty, Verséa Ophthalmics, Visus Therapeutics; Speaker’s bureau: Alcon, Bausch + Lomb, Dompé US, Glaukos, Harrow, Viatris, Sight Sciences.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.

This podcast was developed by PER® editorial staff based on an online activity developed with these faculty.

To learn more about this topic, including information on the diagnosis, testing, and management of patients with NK, go to https://www.gotoper.com/courses/neurotrophic-keratitis-multidisciplinary-approaches-to-enhance-patient-outcomes

Release Date

June 30, 2025

Expiration Date

June 30, 2026

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.